Baihakki, Benladdin H.

HRN: 11-59-17  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/18/2025
CEFTRIAXONE 1G (VIAL)
03/18/2025
03/25/2025
IV
2g
Od
Empiric
Waiting Final Action 
03/18/2025
DOXYCYCLINE 100MG (CAP)
03/18/2025
03/25/2025
ORAL
100mg
Bid
Empiric
Waiting Final Action 
03/18/2025
CEFTRIAXONE 1G (VIAL)
03/18/2025
03/25/2025
IV
2g
Od
Epididymoorchitis With Abscess
Waiting Final Action 
03/18/2025
DOXYCYCLINE 100MG (CAP)
03/18/2025
03/25/2025
ORAL
100
Bid
Epididymoorchitis With Abscess
Waiting Final Action 
03/19/2025
LEVOFLOXACIN 500MG (TAB)
03/19/2025
03/26/2025
PO
500
OD
Scrotal Abscess
Waiting Final Action 
06/17/2025
FLUOCINOLONE ACETONIDE POLYMYXIN B NEOMYCIN, 5ML OTIC SOLUTION
06/17/2025
06/24/2025
EARDROPS
3
Tid
Otitis Externa
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: